India: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2022

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in India

In 2021, after three years of growth, there was significant decline in the Indian human and animal blood market, when its value decreased by -X% to $X. The market value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. Human and animal blood consumption peaked at $X in 2020, and then declined in the following year.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in India

In value terms, human and animal blood production contracted to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 when the production volume increased by X%. Human and animal blood production peaked at $X in 2020, and then contracted in the following year.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from India

In 2021, approx. X tons of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses were exported from India; growing by X% compared with 2020. In general, exports saw significant growth. The pace of growth was the most pronounced in 2020 with an increase of X%. The exports peaked in 2021 and are likely to see steady growth in the near future.

In value terms, human and animal blood exports surged to $X in 2021. Overall, exports saw a significant expansion. The pace of growth appeared the most rapid in 2020 with an increase of X% against the previous year. The exports peaked in 2021 and are likely to continue growth in the near future.

Exports by Country

Finland (X tons) was the main destination for human and animal blood exports from India, accounting for a X% share of total exports. Moreover, human and animal blood exports to Finland exceeded the volume sent to the second major destination, Nepal (X tons), twofold. The third position in this ranking was taken by the United States (X tons), with a X% share.

From 2012 to 2021, the average annual growth rate of volume to Finland amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Nepal (+X% per year) and the United States (+X% per year).

In value terms, the United States ($X) remains the key foreign market for human and animal blood exports from India, comprising X% of total exports. The second position in the ranking was taken by Finland ($X), with a X% share of total exports. It was followed by Vietnam, with a X% share.

From 2012 to 2021, the average annual growth rate of value to the United States amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Finland (+X% per year) and Vietnam (+X% per year).

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2021, reducing by -X% against the previous year. Over the period under review, the export price showed a deep downturn. The growth pace was the most rapid in 2019 an increase of X% against the previous year. The export price peaked at $X per ton in 2012; however, from 2013 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major overseas markets. In 2021, the country with the highest price was the United States ($X per ton), while the average price for exports to Uganda ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Indonesia (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into India

In 2021, human and animal blood imports into India expanded markedly to X tons, surging by X% against the previous year's figure. Over the period under review, imports posted a buoyant expansion. The pace of growth was the most pronounced in 2016 with an increase of X% against the previous year. Over the period under review, imports hit record highs in 2021 and are expected to retain growth in years to come.

In value terms, human and animal blood imports surged to $X in 2021. In general, imports showed resilient growth. As a result, imports attained the peak and are likely to continue growth in the immediate term.

Imports by Country

The United States (X tons), France (X tons) and Switzerland (X tons) were the main suppliers of human and animal blood imports to India, with a combined X% share of total imports. Denmark, New Zealand, China and Italy lagged somewhat behind, together comprising a further X 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by New Zealand (with a CAGR of +X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Switzerland ($X) constituted the largest supplier of human and animal blood to India, comprising X% of total imports. The second position in the ranking was held by the United States ($X), with a X% share of total imports. It was followed by Denmark, with an X% share.

From 2012 to 2021, the average annual growth rate of value from Switzerland stood at +X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (+X% per year) and Denmark (+X% per year).

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2021, increasing by X% against the previous year. In general, import price indicated a remarkable increase from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, human and animal blood import price increased by +X% against 2019 indices. As a result, import price reached the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by the country of origin: the country with the highest price was Switzerland ($X per ton), while the price for China ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Switzerland (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :